Study Links Vaccine Preservative to Autism Severity Crisis
Submitted by MAGA Student
Posted 17 hours ago
Health Myths Exposed: Groundbreaking Study Links Vaccine Preservative to Autism Severity
A recent study has ignited renewed discussions about vaccine safety, revealing a troubling link between thimerosal—a mercury-based preservative used in vaccines—and the severity of autism in children.
The peer-reviewed research, which analyzed data over two decades, found alarming correlations that demand public attention and accountability.
Led by Dr. Cynthia Nevison, the study tracked the health outcomes of 4,960 autistic children from 1992 to 2014.
It pinpointed critical shifts in intellectual disability rates directly associated with thimerosal's presence in vaccines.
The results were stark: the percentage of autistic children with intellectual disabilities dramatically dropped after thimerosal was phased out in most childhood vaccines between 2000 and 2002.
However, after the preservative reappeared in flu shots for pregnant women and infants in 2004, the rate of intellectual disabilities surged back up, reestablishing pre-2000 levels.
Dr. James Lyons-Weiler emphasized the significance of these findings, arguing they contradict claims that rising autism rates are merely a result of enhanced diagnostic practices.
In reality, the data illustrates that eliminating thimerosal led to fewer severe cases of autism, underscoring an urgent need for the CDC and other health authorities to fully acknowledge potential harms.
Despite this alarming evidence, the CDC's Advisory Committee on Immunization Practices recently voted to continue allowing thimerosal in multi-dose vials for flu vaccinations.
This decision raises questions about the commitment to children's health and the transparency of vaccine policies.
The report further highlights discrepancies among different demographic groups, noting that Black and Hispanic children have faced disproportionate rates of autism severity.
Many of these children received thimerosal-laden vaccines through Medicaid programs, raising ethical concerns about the safety of lower-income families.
Experts now advocate for immediate reforms to prioritize the development and distribution of thimerosal-free vaccines.
This study underscores the pressing need for a more cautious approach to vaccine ingredients and a reevaluation of policies that may endanger the health of vulnerable populations.
As public trust in health agencies wanes, it is crucial that policymakers take these findings seriously and work to ensure that the best interests of all children are prioritized in future vaccine formulations.
The potential ramifications of persisting with thimerosal in vaccines serve as a poignant reminder that vigilance and accountability must be at the forefront of public health discourse.
Sources:
globalresearch.ca
naturalnews.com
naturalnews.com
A recent study has ignited renewed discussions about vaccine safety, revealing a troubling link between thimerosal—a mercury-based preservative used in vaccines—and the severity of autism in children.
The peer-reviewed research, which analyzed data over two decades, found alarming correlations that demand public attention and accountability.
Led by Dr. Cynthia Nevison, the study tracked the health outcomes of 4,960 autistic children from 1992 to 2014.
It pinpointed critical shifts in intellectual disability rates directly associated with thimerosal's presence in vaccines.
The results were stark: the percentage of autistic children with intellectual disabilities dramatically dropped after thimerosal was phased out in most childhood vaccines between 2000 and 2002.
However, after the preservative reappeared in flu shots for pregnant women and infants in 2004, the rate of intellectual disabilities surged back up, reestablishing pre-2000 levels.
Dr. James Lyons-Weiler emphasized the significance of these findings, arguing they contradict claims that rising autism rates are merely a result of enhanced diagnostic practices.
In reality, the data illustrates that eliminating thimerosal led to fewer severe cases of autism, underscoring an urgent need for the CDC and other health authorities to fully acknowledge potential harms.
Despite this alarming evidence, the CDC's Advisory Committee on Immunization Practices recently voted to continue allowing thimerosal in multi-dose vials for flu vaccinations.
This decision raises questions about the commitment to children's health and the transparency of vaccine policies.
The report further highlights discrepancies among different demographic groups, noting that Black and Hispanic children have faced disproportionate rates of autism severity.
Many of these children received thimerosal-laden vaccines through Medicaid programs, raising ethical concerns about the safety of lower-income families.
Experts now advocate for immediate reforms to prioritize the development and distribution of thimerosal-free vaccines.
This study underscores the pressing need for a more cautious approach to vaccine ingredients and a reevaluation of policies that may endanger the health of vulnerable populations.
As public trust in health agencies wanes, it is crucial that policymakers take these findings seriously and work to ensure that the best interests of all children are prioritized in future vaccine formulations.
The potential ramifications of persisting with thimerosal in vaccines serve as a poignant reminder that vigilance and accountability must be at the forefront of public health discourse.
Sources:
globalresearch.ca
naturalnews.com
naturalnews.com
Latest News